Article

Answering four key questions about HTA market archetypes

How understanding the nuances can help biopharma companies succeed
Chelsey Campbell, Director, Global Consulting, explains why biopharma companies must understand the commonly established HTA market archetypes to better impact the commercialization process. Enter your information below to learn more.

Pardot Form

Related resources

Newsletter

HTA Quarterly Spring 2026

Webinar

Preparing for 2026 health policy changes and their impact on pricing, affordability, and access

Article

Dangerous projections: How poor survival model choices with immature data can misguide HTA decisions and impact patients